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Sera of mice chronically infected with Trypanosoma cruzi contain antibodies that bind to the surface of living
adult syngeneic heart muscle cells. In a syngeneic system, with nonadherent spleen mononuclear cells as
effector cells and cardiocytes as targets, antibody-dependent cytotoxicity (ADCC), revealed by the liberation of
creatine phosphokinase from damaged cardiocytes, was observed after incorporation of serum samples from
infected mice. Target damage was decreased after absorption with syngeneic myocardium, but absorption with
T. cruzi epimastigotes or trypomastigotes or with syngeneic skeletal muscle had no effect on ADCC. No
complement-dependent lysis against heart muscle cells was detected in the same serum samples. These
observations indicate that serum from chronically chagasic mice contain antibodies that bind to the surface of
living adult syngeneic cardiocytes and are able to exert ADCC, suggesting that they could play a role in the
pathogenesis of the heart damage that occurs in Chagas' disease.
South American trypanosomiasis, or Chagas' disease,
affects several million people in Latin America. About 10 to
15% of humans infected with Trypanosoma cruzi develop a
chronic cardiopathy 10 to 20 years after infection, charac-
terized by abnormalities of the electrocardiogram and/or
cardiomegaly and heart failure (17). Recently, by the use of
more sophisticated diagnostic tools, it has been demon-
strated that most of the 85 to 90% apparently healthy
individuals display some kind of subclinical heart abnormal-
ity, indicating that the heart is almost always damaged in
chronic infection with T. cruzi (2). In the symptomatic stage
of chagasic cardiopathy, a progressive loss of the heart
muscle cells (HMC), scarring, and mild mononuclear inter-
stitial infiltration constitute the morphologic hallmarks of the
disease (1); usually, no parasites are seen at the site of the
lesions (15). The latter fact leads to the postulation of
indirect mechanisms as being responsible for the tissue
damage. During the last decade, evidence has accumulated
to suggest that cell-mediated immune mechanisms could be
operating in the production of lesions (20).
Although antiheart antibodies have been observed in
human (4) and experimental (14) Chagas' disease, their
importance as inducers of tissue damage is unknown.
In the present report we show that serum samples from
mice chronically infected with T. cruzi contain antibodies
able to induce antibody-dependent cytotoxicity of nonadher-
ent spleen mononuclear cells against syngeneic adult car-
diocytes and suggest that antibody-dependent cytotoxicity
(ADCC) can be a mechanism of heart damage in chronic
Chagas' disease.
MATERIALS AND METHODS
Induction of chronic Chagas' disease. Chronic Chagas'
disease was induced as previously described (12). In brief,
3-month-old female BALB/c mice were each infected with 25
trypomastigotes of the Tulahuen strain of T. cruzi. Parasite-
mia was determined weekly, and surviving animals which
showed circulating parasites during the first month postin-
fection (p.i.) were used for the experiments. At 1, 2, 3, and
* Corresponding author.
4 months p.i., animals were killed by exsanguination, sera
were collected and kept at -20°C, and the hearts were
removed from the animals for histological study. Control
serum samples and hearts were obtained from noninfected
mice of matching age and sex.
Preparation of heart cell suspension. Hearts of noninfected
3-month-old female BALB/c mice were removed aseptically,
cut into 1-mm3 fragments in Hanks balanced salt solution,
washed once in Dulbecco phosphate-buffered saline (PBS)
without Ca2+ or Mg2+ (Sigma Chemical Co., St. Louis,
Mo.), and incubated in PBS containing 1 mg of trypsin
(Sigma) per ml and 1 mg of collagenase (Sigma) per ml at
37°C with constant agitation. The supematant containing
released cells was removed every 10 min into an equal
volume of cold RPMI 1640 medium (GIBCO Laboratories,
Grand Island, N.Y.) until most of the myocardium was
disrupted. The pooled cell suspension was sedimented at 1 x
g for 30 min at 4°C, and the supernatants were washed three
times with cold RPMI 1640 medium by centrifugation for 5
min at 100 x g. Phase-contrast microscopy of the collected
cells showed that they were isolated single cardiocytes with
more than 95% viability according to the Trypan blue dye
exclusion test.
Preparation of splenocyte suspension. The spleens of non-
infected BALB/c mice were removed aseptically into Hanks
balanced salt solution and passed gently through a 100-mesh
steel screen. The cells were centrifuged at 150 x g for 15
min, and the pellet was suspended in a buffered ammonium
chloride solution for 1 min at room temperature to lyse
erythrocytes. The suspension was diluted in RPMI 1640
medium and centrifuged in a Ficoll-Hypaque gradient. The
mononuclear fraction was collected in RPMI 1640 medium
containing 5% fetal calf serum and incubated for 2 h in
10-cm-diameter plastic petri dishes to remove adherent cells.
The supernatant, containing the nonadherent cells, was
washed three times in RPMI 1640 medium, cells were
counted, and viability was assessed by the Trypan blue
exclusion test.
Immunohistochemistry. Isolated syngeneic HMC were
suspended for 1 h at room temperature in serum from
noninfected or chagasic mice diluted 1/20 in PBS (pH 7.2).
After three washings in PBS, cells were centrifuged at 150 x
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g, suspended in small drops of PBS, extended on glass
slides, dried at room temperature, and fixed in cold (4°C)
acetone. Smears were incubated for 1 h at room temperature
with anti-mouse immunoglobulin G (IgG) goat antiserum
(Dako, Copenhagen, Denmark), thoroughly washed in PBS,
and posttreated for 30 min with mouse peroxidase-antiperox-
idase complex (Dako). Enzyme activity was demonstrated
by incubation in 0.1% diaminobenzidine chlorhydrate in
0.01% hydrogen peroxide.
ADCC assay. Isolated HMC (105) were incubated with
syngeneic nonadherent spleen cells in a 1/30 target/effector
cell ratio in RPMI 1640 tissue culture medium containing
10% fetal calf serum. For determination of ADCC, heat-
inactivated (56°C for 60 min) serum from either chagasic or
noninfected mice was added to obtain a final dilution of 1:40.
The samples were then incubated for 16 h at 37°C in a 5%
CO2 atmosphere. At the end of the incubation, cells were
spun down by centrifugation at 400 x g for 15 min, and cell
damage was estimated by the liberation of creatine phospho-
kinase (CK) to the supernatant. Triplicate measurements
were made with serum from each mouse. As a control, tubes
with the same number of HMC were incubated in parallel
under the same conditions with tissue culture medium alone,
with chagasic serum without mononuclear spleen cells, or
with splenocytes alone. Enzyme activity was determined by
a kinetic enzymatic method, using a commercial kit (CK-
NAC; Boehringer Mannheim Biochemicals). ADCC was
estimated as the percentage of the total activity of a similar
number of HMC lysed with 1% Triton X-100 which was
liberated to the supernatant, by using the following equation:
ADCC (%) = [(CK released with test serum - CK released
without serum)/(Total CK)] x 100. For the cytotoxicity
assay, the liberation of CK was used instead of the widely
used 51Cr assay to determine cell damage, because in previ-
ous experiments a marked liberation of the isotope was
noticed after 16 h of incubation. This handicap was not
present when shorter periods were used. For that reason, we
used that assay to study complement-dependent lysis. CK is
an enzyme present in high concentration in striated muscle,
and its determination in serum is currently used for the
diagnosis of myocardium infarction or skeletal muscle de-
struction in humans. Since CK is practically absent in
mononuclear spleen cells, it can be safely assumed that the
liberated enzyme originated almost exclusively from the
damaged cardiocytes. In experiments done with serum sam-
ples from nonchagasic mice, spontaneous release of the
enzyme was minimal during the 16-h assay. The possibility
that CK was present in the serum samples from chagasic
mice could be ruled out, since the serum samples were
diluted 1:40 and were preheated at 56°C for 30 min, which
inactivates the enzyme.
Absorptions. Test serum samples used for the ADCC
assay were absorbed into T. cruzi epimastigotes and trypo-
mastigotes and BALB/c heart and skeletal muscle. Epimasti-
gotes were grown in diphasic medium. Parasites were
washed three times in PBS and kept at -70°C. Trypomasti-
gotes were grown in Vero cell cultures, collected from the
supernatant, concentrated by centrifugation at 1,500 x g for
30 min, and washed three times in PBS. Epimastigotes and
trypomastigotes were disrupted by successive freezing and
thawing (five times) and sonication. The material obtained
from approximately 108 parasites was used to absorb 0.2 ml
of serum. Heart, masseter, and quadriceps were disrupted in
a homogenizer (Potter-Elvehem) equipped with a tightly
adjusted Teflon pestle and suspended 1:40 (vol/vol) in mini-
mal essential medium. Serum (1 ml) was absorbed into 500
mg of protein (by the Lowry method [14a]). All absorptions
were done for 24 h at 4°C, and serum samples were cleared
by centrifugation at 10,000 x g for 1 h at 4°C.
For each animal, determinations were made in triplicate.
The number of experiments is detailed in Tables 1 to 4.
Preparation of allogeneic antiheart antiserum. Outbred
female Swiss albino mice were immunized with a homoge-
nate of whole BALB/c mouse heart. The whole heart was
dissected, minced with scissors into small pieces, thoroughly
washed in PBS, suspended 1:10 (wt/vol) in PBS, homoge-
nized in a homogenizer (Potter-Elvehem) with a tightly
adjusted Teflon pestle, and kept at -70°C. Each mouse
received three weekly injections of 0.2 ml of the homogenate
containing 500 ,ug of protein incorporated in complete
Freund adjuvant and administered in multiple subcutaneous
sites; a booster of the same amount of homogenate was given
by the intraperitoneal route. At 1 week later, animals were
exsanguinated, and the collected serum was kept at -20'C.
The antiheart activity of the antiserum was assessed by
immunofluorescence by using anti-mouse IgG rabbit antise-
rum labeled with fluorescein isothiocyanate (Cappel Labo-
ratories, Cochranville, Pa.) and isolated adult cardiocytes
from BALB/c mice as targets.
Assay of complement-dependent lysis. Isolated HMC sus-
pended in RPMI 1640 medium plus 5% fetal calf serum were
incubated with 51Cr (sodium chromate, 100 to 200 mCi/mg;
Comision Nacional de Energia At6mica, Buenos Aires,
Argentina) for 1 h at 37°C at 3 ,uCi of 51Cr per 105 cells. HMC
were washed three times in cold RPMI 1640 medium, and 104
cells were incubated in RPMI 1640 medium containing
preheated (56°C for 1 h) test sera (normal, chagasic, and
allogeneic mouse antisera) diluted 1:20. After 45 min of
incubation at 37°C, fresh guinea pig serum as a source of
complement was incorporated into a final 1:10 dilution, and
the preparation was incubated for a further 30 min. Cells
were spun down by centrifugation at 150 x g, and the
radioactivity of the supernatant was determined. The same
procedure was performed with preheated (56TC for 1 h)
guinea pig serum instead of the normal serum. Cell lysis was
calculated as follows: % lysis = [(Experimental - Sr)/(Mr -
Sr)] x 100, where Experimental is the counts per minute of
cardiocytes plus serum and complement, Sr is the spontane-
ous release of 51Cr from cardiocytes, and Mr is the maximal
release of 51Cr from cardiocytes.
Histological studies. The hearts were fixed in Bouin fluid,
and each was divided in half and embedded in paraffin.
Semiserial sections every 200 ,um were stained with hema-
toxylin and eosin.
RESULTS
Histology. The histological study showed that the hearts of
all mice chronically infected with T. cruzi presented a heavy
mononuclear infiltrate. In animals studied at 1 and 2 months
p.i., the atria were more affected than the ventricles, but at
3 and 4 months after infection the ventricles also showed
interstitial infiltrates with a predominant subendocardial or
subepicardial localization. In places fibrosis and scarring
were present (Fig. 1).
Immunohistochemistry. The peroxidase-antiperoxidase
(PAP) stain revealed autologous IgG bound to the surface of
living cardiocytes incubated either with serum samples from
chagasic mice or with allogeneic antiheart antisera (Fig. 2).
When HMC were incubated with serum samples from non-
infected mice, no binding of immunoglobulin was observed
(Fig. 3).
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FIG. 2. IgG bound to the surface of isolated cardiocytes after
incubation with serum samples from chagasic mice. This is seen as
a heavily stained deposit. Staining was with PAP. Magnification,
x450.
FIG. 3. Lack of bound IgG when isolated cardiocytes are incu-
bated with serum samples from noninfected mice. Staining was with
PAP. Magnification, x450.
collected at 1, 2, 3, and 4 months p.i. In mice studied at 1
month p.i., no ADCC was observed (Table 3). At 2 months
p.i. half the animals showed antiheart reactivity, which was
present in the sera of all mice studied at 3 and 4 months p.i.
Absorption of chagasic serum by syngeneic heart homo-
genate significantly decreased the liberation of CK, but
absorption by T. cruzi epimastigotes or trypomastigotes or
by two skeletal muscles, masseter (rich in white fibers) and
quadriceps (rich in red fibers), did not change the ADCC
activity of the chagasic sera (Table 4).
Complement lytic assay. No cardiocyte damage was ob-
served when cells were incubated with serum samples from
normal or chagasic mice or with antiallogeneic heart antise-
rum in the presence of fresh guinea pig serum as a source of
complement.
DISCUSSION
The pathogenesis of the slow and progressive heart dam-
age that occurs in Chagas' disease is poorly understood.
TABLE 1. Liberation of CK from cardiocytes incubated with
syngeneic nonadherent splenocytes and serum samples
from chagasic or control mice
CK liberated ina:
Animal no.











a All data represent the percentage of the total CK liberated to the
supernatant after 16 h of incubation. The means ± standard deviations are
18.04 ± 4.29 (P < 0.01 by the Student t test) for infected mice and 3.38 ± 1.24
(P < 0.01 by the Student t test) for noninfected mice.
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TABLE 2. Liberation of CK from cardiocytes incubated




MEMb MEM + serum Lymphocytes
1 2.1 2.8 2.6
2 2.0 1.7 1.9
3 4.2 5.2 4.6
4 4.9 5.0 4.6
5 1.7 2.4 2.2
6 2.0 2.6 2.3
7 1.8 2.8 2.4
a Data represent the percentage of the total CK liberated to the medium
after 16 h of incubation. The means ± standard deviations are 2.6 ± 1.0 for
MEM, 3.1 ± 1.2 for MEM + serum, and 2.9 ± 1.0 for lymphocytes. CK
liberated from 2 x lo' cardiocytes after detergent lysis: 274 ± 7.7 IU.
b MEM, Minimal essential medium.
Different mechanisms have been postulated to explain the
tissue alterations. Koberle et al. maintain that it is secondary
to a chronic heart denervation, since it is known that T. cruzi
infection leads to a massive destruction of autonomic neu-
rons (10). In a different line of thinking, cell-mediated
immune mechanisms have been held to be the main cause of
the heart abnormalities. This assumption is based on the
facts that immunization with subcellular fractions of the
parasite induces a chronic myocarditis in mice (18) and heart
failure in rabbits (26) and that lymphocytes from chagasic
animals are cytotoxic for allogeneic embryonal HMC in in
vitro assays (21). In addition, transfer of splenocytes from
chagasic to normal syngeneic mice induces a transient myo-
carditis (13). The role that antibodies may play in the
pathogenesis of heart lesions is less clear. Although several
previous studies have shown that there are antigenic deter-
minants common to mammalian cells and T. cruzi, such as
striated muscle sarcoplasmic reticulum (19), neurons (27),
and laminin (24), the possibility that antibodies raised against
those components play a role in the pathogenesis of tissue
damage has not been established.
Antibodies with antiheart reactivity were shown to be
present in serum samples from chagasic humans early in the
1970s (3). Since their prevalence appeared to be higher in
patients with cardiopathy than in asymptomatic individuals
TABLE 3. Liberation of CK from cardiocytes incubated with
syngeneic nonadherent splenocytes and serum samples collected
from chagasic or control mice at 1, 2, 3, and 4 months p.i.
CK liberated at following month p.i.:
Mice
1 2 3 4
Normal
1 3.9 2.8 2.8 6.2
2 3.9 1.9 2.1 2.2
3 1.7 2.1 4.5 2.7
4 3.2 2.2 3.6 3.9
Mean SD 3.2 + 0.9 2.2 ± 0.3 3.2 ± 0.9 3.7 ± 1.5
Chagasic
1 4.6 4.7 14.6 25
2 5.6 17.6 16.2 15.4
3 7.3 5.2 17.2 24
4 5.1 18.1 13.2 18.7
Mean ± SD 4 ± 0.1 11.4 ± 6.4 15.3 ± 1.5 20.7 ± 3.9
a All data represent the percentage of the total CK liberated to the
supernatant after 16 h of incubation.
TABLE 4. Effect of absorptions on ADCC
against myocardiocytes
CK liberated (mean ± SEM) ina:
Absorbing cells
Noninfected mice Chagasic mice
None 2.83 ± 0.76 16.33 ± 4.65
Myocardium 3.55 ± 0.15 3.46 ± 0.4
Masseter 3.45 ± 0.25 11.3 ± 2.03
Quadriceps 3.30 ± 0.40 13.46 ± 4.69
Epimastigotes 2.95 ± 0.05 12.2 ± 1.02
Trypomastigotes 1.70 ± 0.3 12.57 ± 2.23
a All data represent the percentage ofCK liberated to the supernatant. Four
mice were used for each experiment.
(6), it was postulated that they could exert a pathogenic
effect. This interpretation was supported by the finding of
autologous immunoglobulins and complement in the endo-
thelia and sarcolemmas of heart biopsies from chagasic
humans (4, 16). However, those findings have not been
confirmed recently, and doubts were raised about the valid-
ity of these observations (7, 11). Since studies were per-
formed by immunohistochemical methods and with frozen
myocardium as the target, the possibility exists that antigens
are destroyed during processing. Recently, in a different
approach, a series of experiments have shown that serum
samples from chagasic humans contain immunoglobulin that
binds living atrial myocardium, where they induce an ago-
nistic P-adrenergic effect (22, 23), indicating that living HMC
can be adequate targets for the demonstration of antiheart
antibodies in Chagas' disease. However, since in those
studies the beating atria were from rats and the serum
samples were from humans, the possibility that the antibod-
ies operate only in a xenogeneic system was not discarded.
Moreover, the same group who described antiheart reactiv-
ity by means of immunofluorescence techniques recently
reported that serum samples from chagasic humans react
only with murine myocardium. When human myocardium
was used for the reaction, no antibody binding was observed
(9).
Our results show that the sera of mice chronically infected
with T. cruzi contain antibodies that react with the mem-
branes of living adult syngeneic cardiocytes. In our experi-
ments, complement-mediated lysis of HMC cells could not
be demonstrated. The possibility that HMC are resistant to
complement-mediated lysis or that the bound IgG does not
activate the complement system has been considered; but
since no studies were performed to identify the subclass of
IgG bound to the surface of living cardiocytes or to establish
the presence of activated components of the complement
cascade, no explanation can be put forward to explain this
phenomenon. Despite some reports that documented the
presence of C3 in the endothelia and sarcolemmas in heart
biopsies of chagasic humans (5, 16), its participation in the
pathogenesis of tissue damage appears unlikely, since vas-
culitis and polymorphonuclear infiltration, the morphologic
hallmarks of complement activation, are not present in
chagasic cardiopathy.
Since the antibodies present in serum samples from cha-
gasic mice were able to induce ADCC, the possibility that
they play some role in the development of heart damage
appears reasonable. Antiheart antibodies can be detected in
several human diseases, such as postcardiotomy, Dressler
syndrome, acute rheumatic fever (8), and congenital com-
plete heart block (25). Their pathogenetic role remains
speculative, and it is not known whether they are an epiphe-
nomenon secondary to the heart damage.
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Apparently the antibodies including ADCC were heart
specific. They could be absorbed with myocardium, but not
with skeletal muscle. Cross-reactivity between T. cruzi and
the heart appears unlikely, since reactivity could not be
abolished by absorption with either epimastigotes or trypo-
mastigotes. Moreover, ADCC antibodies were detected only
after 2 months p.i., and a strong anti-T. cruzi immune
response was already operating since day 15 p.i.
The results presented in this report lend support to the
opinion that antiheart antibodies participate in the pathogen-
esis of the heart damage in Chagas' disease and could
represent a mechanism of increase in the severity and
perpetuation of the cardiopathy. Further studies, especially
on humans, are necessary to ascertain this possibility.
ACKNOWLEDGMENT
This work was supported by a grant from Secretaria de Estado de
Ciencia y Tecnica, Argentina.
LITERATURE CITED
1. Andrade, Z. A. 1976. Chagas' disease: pathology of the cardiac
lesions. Am. Trypanosomiasis Res. Pan American Health Or-
ganization Sci. Publ. 318:146-151.
2. Carrasco, G. H., E. Palacios Pru, C. de Scorza, A. Raugel, C. L.
Sanota, C. Molina, and A. Fuenmayor. 1982. La biopsia mio-
cardica: un recurso diagn6stico? Experiencia clfnica en pa-
cientes chagasicos y con otras miocardiopatfas. Rev. Latinoam.
Cardiol. 3:105-115.
3. Cossio, P. M., C. Diez, A. Szarfman, E. Kreutzer, B. Candiolo,
and R. Arana. 1974. Chagasic cardiopathy. Demonstration of a
serum gamma globulin factor which reacts with endocardium
and vascular structures. Circulation 49:13-21.
4. Cossio, P. M., R. P. Laguens, C. Diez, A. Szarfman, and R.
Arana. 1974. Chagasic cardiopathy. Antibodies reacting with
plasma membrane of striated muscle and endothelial cells.
Circulation 50:1252-1259.
5. Cossio, P. M., R. P. Laguens, E. Kreutzer, E. Diez, A. Segal, and
R. Arana. 1977. Chagasic cardiopathy. Immunopathologic and
morphologic studies in myocardial biopsies. Am. J. Pathol.
86:533-544.
6. Diez, C., A. Szarfman, E. Kreutzer, B. Candiolo, R. Arana, and
P. M. Cossio. 1976. Asociaci6n entre cardiopatfa y serologfa
positiva para trypanosomiasis americana en un area de la
Argentina endemica para la enfermedad de Chagas. Medicina
(Buenos Aires) 36:229-233.
7. Higuchi, M. L., E. A. Lopes, L. B. Saidanha, A. C. Barretto, N.
Stoif, G. Belotti, and I. Pileggi. 1986. Immunopathologic studies
in myocardial biopsies of patients with Chagas' disease and
idiopathic cardiomyopathy. Rev. Inst. Med. Trop. Sao Paulo
28:87-90.
8. Kaplan, M., and L. Rakita. 1978. Myocardial disease, p.
1502-1521. In M. Samter (ed.), Immunological diseases, vol. II.
Little, Brown & Co., Boston.
9. Khoury, E. L., C. Diez, P. M. Cossio, and R. Arana. 1983.
Heterophil nature of EVI antibody in Trypanosoma cruzi infec-
tion. Clin. Immunol. Immunopathol. 27:283-288.
10. Koberle, F. 1%1. Patologia y anatomfa patol6gica de la enfer-
medad de Chagas. Bol. Of. Sanit. Panam. 51:404-428.
11. Laguens, G. E., J. F. Magri, R. Cabuli, and R. P. Laguens. 1982.
Presencia de anticuerpo EVI. Correlaci6n clfnica en pacientes
chagasicos. Medicina (Buenos Aires) 42:923-926.
12. Laguens, R. P., P. M. Cabeza Meckert, M. A. Basombrio, J. G.
Chamb6, P. M. Cossio, R. Arana, and R. Gelpi. 1980. Infecci6n
cr6nica del rat6n con Trypanosoma cruzi. Modelo experimental
de enfermedad de Chagas. Medicina (Buenos Aires) 40(1):
33-39.
13. Laguens, R. P., P. M. Cabeza Meckert, J. G. Chamb6, and R.
Gelpi. 1981. Chronic Chagas' disease in the mouse. II. Transfer
of the heart disease by means of immunocompetent cells.
Medicina (Buenos Aires) 41:40-43.
14. Laguens, R. P., P. M. Cabeza Meckert, and R. Gelpi. 1981.
Chronic Chagas' disease in the mouse. I. Electrocardiographic
and morphological patterns of cardiopathy. Medicina (Buenos
Aires) 41:35-39.
14a.Lowry, 0. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall.
1951. Protein measurement with the Folin phenol reagent. J.
Biol. Chem. 193:265-275
15. Margarinho Torres, C. B. 1930. Patogenia de la miocarditis
cr6nica en la enfermedad de Chagas, p. 902-916. In V Reuni6n
de la Soc. Arg. de Patol. Reg. del Norte, vol. 2.
16. Molina, H. A., J. Milei, and R. Storino. 1984. Chronic Chagas
myocardiopathy. Demonstration of the "in vivo" bound immu-
noglobulins in heart structures by the immunoperoxidase tech-
nique. Cardiology 71:297-306.
17. Rosenbaum, M. 1964. Chagasic myocardiopathy. Prog. Cardio-
vasc. Dis. 7:199-225.
18. Ruiz, A. M., M. Esteva, P. M. Cabeza Meckert, R. P. Laguens,
and E. L. Segura. 1985. Protective immunity and pathology
induced by inoculation of mice with different subcellular frac-
tions of Trypanosoma cruzi. Acta Trop. 42:299-309.
19. Sadigursky, M., A. M. Acosta, and C. A. Santos Buch. 1982.
Muscle sarcoplasmic reticulum antigen shared by a Trypano-
soma cruzi clone. Am. J. Trop. Med. Hyg. 31:934-941.
20. Santos Buch, C. A. 1979. American trypanosomiasis. Chagas'
disease. Int. Rev. Exp. Pathol. 19:63-100.
21. Santos Buch, C. A., and A. R. L. Texeira. 1974. The immunology
of experimental Chagas' disease. III. Rejection of allogenic
heart cell in vitro. J. Exp. Med. 140:38-53.
22. Sterin-Borda, L., P. M. Cossio, A. L. Gimeno, C. Diez, R. P.
Laguens, P. M. Cabeza Meckert, and R. Arana. 1976. Effect of
chagasic sera on the rat isolated atrial preparation: immunolog-
ical, morphological and functional aspects. Cardiovasc. Res.
10:613-622.
23. Sterin-Borda, L., S. Fink, C. Diez, P. M. Cossio, and M. M. de
Bracco. 1982. Beta-adrenergic effect of antibodies from chagasic
patients and normal human chagasic lymphocytes on isolated
rat atria. Clin. Exp. Immunol. 50:534-540.
24. Szarfman, A., V. P. Terranova, S. L. Rennard, J. M. Foidart,
F. M. Lima, J. I. Scheinman, and G. R. Martin. 1982. Antibod-
ies to laminin in Chagas' disease. J. Exp. Med. 155:1161-1171.
25. Taylor, P. V., S. Scott, L. Gerlis, E. Esscher, and 0. Scott. 1986.
Maternal antibodies against fetal cardiac antigens in congenital
complete heart block. N. Engl. J. Med. 315:667-672.
26. Texeira, A. R. L., M. L. Teixeira, and C. A. Santos Buch. 1975.
The immunology of experimental Chagas' disease. IV. Produc-
tion of lesions in rabbits similar to those of chronic Chagas'
disease in man. Am. J. Pathol. 80:163-180.
27. Wood, J. N., L. Hudson, T. M. Lessel, and M. Yamamoto. 1982.
A monoclonal antibody defining determinants on subpopula-
tions of mammalian neurons and Trypanosoma cruzi parasites.
Nature (London) 296:34-38.
VOL. 56, 1988
